quidel most logical way to play elevated testing levels: oppenheimer's jared holz
Published 2 years ago • 1.5K plays • Length 2:39
Download video MP4
Download video MP3
Similar videos
-
5:41
mizuho's jared holz on what trump's fda pick means for biotech innovation
-
1:44:21
shock retirement.
-
7:09
a biotech self-correction is in store, says oppenheimer's jared holz
-
4:42
'overuse' is causing healthcare insurer headwinds, says mizuho's jared holz
-
4:08
weight loss drug market is just beginning to take off, says mizuho's jared holz
-
28:03
ex-google ceos statement on 2025 ai is stunning...
-
13:35
training ai takes heavy toll on kenyans working for $2 an hour | 60 minutes
-
49:41
blind spots (w/dr. marty makary) | the vpzd show ep. 34
-
4:53
here's who could benefit from biden's biotech initiative, according to oppenheimer's jared holz
-
3:56
it doesn't seem like there's too much momentum for healthcare stocks, says mizuho's jared holz
-
6:07
oppenheimer's john stoltzfus: we're still very much in a bull market supported by fundamentals
-
3:33
pfizer pill approval news already priced into stock: oppenheimer's jared holz
-
5:27
eli lilly's drop after earnings is a buying opportunity, says mizuho's jared holz
-
6:24
openai is the definitive consumer brand for ai at this point, says bedrock capital's geoff lewis
-
4:02
oppenheimer's ari wald charts out key level for high-growth stocks
-
5:12
structure therapeutics is a 'no-brainer takeout' target, says mizuho's jared holz
-
3:55
consumers and earnings have shown remarkable resilience, says oppenheimer's john stoltzfus
-
4:34
fundamentals have improved despite cautious guidance, says oppenheimer's john stoltzfus
-
1:32
s&p price target raised to 4,700 by oppenheimer’s stoltzfus
-
3:27
nike earnings are a testament to the company's digital capabilities: oppenheimer's nagel
-
5:47
drugs for obesity are a massive market, says mizuho's jared holz
-
5:13
obesity drug enthusiasm can continue in 2024: mizuho's jared holz
Clip.africa.com - Privacy-policy